Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1

Detalles Bibliográficos
Autores principales: Hemming, Matthew L., Nathenson, Michael J., Lin, Jia-Ren, Mei, Shaolin, Du, Ziming, Malik, Karan, Marino-Enriquez, Adrian, Jagannathan, Jyothi P., Sorger, Peter K., Bertagnolli, Monica, Sicinska, Ewa, Demetri, George D., Santagata, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055910/
https://www.ncbi.nlm.nih.gov/pubmed/32133433
http://dx.doi.org/10.1200/PO.19.00287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055910/
https://www.ncbi.nlm.nih.gov/pubmed/32133433
http://dx.doi.org/10.1200/PO.19.00287

Ejemplares similares